Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Ceapro Inc V.CZO

Alternate Symbol(s):  CRPOF

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.


TSXV:CZO - Post by User

Comment by Mofonomoon Jun 23, 2021 4:15pm
150 Views
Post# 33435923

RE:Clinical Trials Page Updated June 8

RE:Clinical Trials Page Updated June 8Thanks for sharing this update. You can view the changelog or history of updates via this link:

https://clinicaltrials.gov/ct2/history/NCT03857256?A=1&B=9&C=Side-by-Side#StudyPageTop

archeo753 wrote:
https://clinicaltrials.gov/ct2/show/record/NCT03857256

Not exactly sure what has changed but , from memory, it looks like they've added BetAvena to the title and might have changed the primary completion date to Aug 31, 2021 but not totally sure what it said before.  So looks like the end is in sight.  Hopefully, they will publish preliminary findings before the end of the year.  If the results are good I think it will be hard to keep secret until publication of the final study.


<< Previous
Bullboard Posts
Next >>